Description
CD Bioparticles offers anti-TFR aptamer synthesis and modification services and provides a valuable reference for studying the role of aptamer-targeted TFR proteins in cancer drug delivery through aptamer synthesis and modification. We are able to exploit the unique advantages of aptamers in disease-targeted diagnosis and treatment.